A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema

Recruiting

Phase 2

PF-08049820A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema

Sponsor:

Pfizer

Code:

NCT07216027

Conditions

Atopic Dermatitis

Eczema, Atopic

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

PF-08049820

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-01-02. This information was provided to ClinicalTrials.gov by Pfizer on 2025-12-05.